LeeM.EllisMD
Oncology • Houston, TXGastrointestinal Cancer
Professor of Surgery, Department of Surgical Oncology, Division of Surgery, Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX MD Anderson Cancer Center Global Academic Programs Executive Director for Translational Research Vice Chair Translational Medicine, SWOG, Portland, OR Deputy Editor, JAMA Oncology
Dr. Ellis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1515 Holcombe Blvd
PO Box 301402
Houston, TX 77230Phone+1 713-792-6926- Is this information wrong?
Summary
- It is an honor to serve the cancer community in my positions with ASCO, ESMO, AACR, NCI, EORTC, JAMA Oncology, and more. One highlight of my career is raising the issue of Research Integrity in a Nature Comment, and Lancet Oncology Comment over a decade ago.
Education & Training
University of Texas M D Anderson Cancer CenterFellowship, Complex General Surgical Oncology, 1990 - 1992
University of FloridaResidency, Surgery, 1983 - 1990
University of Virginia School of MedicineClass of 1983
Certifications & Licensure
TX State Medical License 1993 - 2025- TX State Medical License 1991 - 2025
CA State Medical License 1993 - 1994
AL State Medical License Active through 1992
FL State Medical License 1984 - 1990- American Board of Surgery Surgery
Awards, Honors, & Recognition
- Fellow of ASCO American Society of Clinical Oncology
- AACR Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research American Association for Cancer Research, 2022
- 2021 Walter Reed Distinguished Alumni Award University of Virginia Medical Alumni Association, 2022
- Join now to see all
Clinical Trials
Publications & Presentations
PubMed
- 1 citationsVincristine Enhances the Efficacy of MEK Inhibitors in Preclinical Models of KRAS-mutant Colorectal Cancer.Susmita Ghosh, Fan Fan, Reid T Powell, Jason Roszik, Yong Sung Park, Clifford Stephan, Manu Sebastian, Lin Tan, Alexey V Sorokin, Philip L Lorenzi, Scott Kopetz, Lee M...> ;Molecular Cancer Therapeutics. 2023 Aug 1
- 4 citationsLiver Endothelium Promotes HER3-Mediated Cell Survival in Colorectal Cancer with Wild-Type and Mutant KRAS.Moeez Rathore, Wei Zhang, Michel'le Wright, Rajat Bhattacharya, Fan Fan, Ali Vaziri-Gohar, Jordan Winter, Zhenghe Wang, Sanford D Markowitz, Joseph Willis, Lee M Ellis...> ;Molecular Cancer Research. 2022 Jun 3
- 9 citationsOverall Survival in Phase 3 Clinical Trials and the Surveillance, Epidemiology, and End Results Database in Patients With Metastatic Colorectal Cancer, 1986-2016: A Sy...Chan Shen, Daniel Tannenbaum, Robert Horn, Jane Rogers, Cathy Eng, Shouhao Zhou, Benny Johnson, Scott Kopetz, Van Morris, Michael Overman, Christine Parseghian, George...> ;JAMA Network Open. 2022 May 2
- Join now to see all
Journal Articles
- Combining MEK and SRC inhibitors for treatment of colorectal cancer demonstrate increased efficacy in vitro but not in vivoFan Fan 1, Susmita Ghosh 1, Reid Powell 2, Jason Roszik 3, Yongsun Park 2, Mary Sobieski 2, Alexey Sorokin 4, Clifford Stephan 2, Scott Kopetz 4, Lee M Ellis 1 5, Raja..., plos one
- Colorectal Premalignancy Is Associated with Consensus Molecular Subtypes 1 and 2L M Ellis, P M Lynch, J A Willis, S Kopetz, Annals of Oncology
- Words Matter: Restoring Respect and Dignity When Referring to Individuals with CancerLee M Ellis, Charles D Blanke, Cancer
Lectures
- The 15th International Symposium on Anti-Angiogenic Therapy: Recent Advances and Future Directions in Basic and Clinical Care ResearchThe University of Texas, M. D. Anderson Cancer Center, San Diego, California - 1/31/2013
- 10th International Congress on Targeted Therapies in CancerPhysicians' Education Resource, LLC, Washington, Dist Of Col - 8/17/2012
Press Mentions
AACR Announces Recipients of Its 2022 Scientific Achievement Awards and LectureshipsApril 4th, 2022- Drs. Roger B. Cohen, Lee M. Ellis and John L. Marshall Join Actuate Therapeutics’ Scientific Advisory BoardOctober 18th, 2022
- JAMA Network Articles of the Year 2019December 3rd, 2019
- Join now to see all
Grant Support
- Paracrine Role Of Endothelial Cells On The Colorectal Cancer Stem Cell PhenotypeNational Cancer Institute2012
- Function Of VEGF Receptor-1 On Colorectal Cancer CellsNational Cancer Institute2005–2009
- Training Of Academic Surgical OncologistsNational Cancer Institute2000–2009
- VEGF Regulation In Human Colon CancerNational Cancer Institute1999–2003
- Pilot--Angiopoietins 1 &2 In Colon Cancer AngiogenesisNational Cancer Institute2001–2002
Committees
- Member, ESMO Declaration of Interest Committee 2022 - Present
- Committee Member, EORTC Scientific Audit Committee 2018 - Present
- Member and Chair, ASCO Cancer Research Committee 2010 - 2014
Professional Memberships
- Member
- Board of Directors 2018-2022
- Member
- European Society of Medical OncologyMember
Hospital Affiliations
University of Texas M.D. Anderson Cancer CenterHouston, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
